Correction:  EGFR  C797S,  EGFR  T790M and  EGFR  sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR

Jordan Madic; Cécile Jovelet; Julien Lopez; Barbara André; Jean Fatien; Isabelle Miran; Aurélie Honoré; Laura Mezquita; Benjamin Besse; Ludovic Lacroix; Magali Droniou

doi:10.18632/oncotarget.26686

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR

PDF | How to cite

Oncotarget. 2019; 10:1345-1345. https://doi.org/10.18632/oncotarget.26686

Metrics: PDF 1929 views | ?

Jordan Madic^1,*, Cécile Jovelet^2,*, Julien Lopez¹, Barbara André¹, Jean Fatien³, Isabelle Miran², Aurélie Honoré², Laura Mezquita⁵, Benjamin Besse⁵, Ludovic Lacroix^2,4,* and Magali Droniou^1,*

¹ Stilla Technologies, 1 Mail du Professeur Georges Mathé, Villejuif, France
² Plateforme de Génomique, Module de Biopathologie Moléculaire et Centre de Ressources Biologiques, AMMICa, INSERM US23/CNRS UMS3655, Gustave Roussy, Villejuif, France
³ Ecole Polytechnique, Route de Saclay, Palaiseau, France
⁴ Département de Biologie et Pathologie Médicales, Institut Gustave Roussy, Villejuif, France
⁵ Département d’Oncologie Médicale, Gustave Roussy, Villejuif, France
^* These authors have contributed equally to this work

Published: February 12, 2019

This article has been corrected: The correct author name is given below:

Laura Mezquita

Original article: Oncotarget. 2018; 9:37393-37406. DOI: https://doi.org/10.18632/oncotarget.26446.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26686

Publication Alerts

Post-Publication Promotion

Corrections:

Correction: EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR